Monden M - Search Results

1

Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma.

Noda T, Nagano H, Takemasa I, Yoshioka S, Murakami M, Wada H, Kobayashi S, Marubashi S, Takeda Y, Dono K, Umeshita K, Matsuura N, Matsubara K, Doki Y, Mori M, Monden M. Noda T, et al. Among authors: monden m. Br J Cancer. 2009 May 19;100(10):1647-58. doi: 10.1038/sj.bjc.6605064. Epub 2009 Apr 28. Br J Cancer. 2009. PMID: 19401692 Free PMC article.

2

Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches.

Sakon M, Nagano H, Dono K, Nakamori S, Umeshita K, Yamada A, Kawata S, Imai Y, Iijima S, Monden M. Sakon M, et al. Among authors: monden m. Cancer. 2002 Jan 15;94(2):435-42. doi: 10.1002/cncr.10246. Cancer. 2002. PMID: 11900229 Free article.

3

[Development and research of the new therapy for hepatocellular carcinoma--combined interferon and 5-fluorouracil therapy].

Nagano H, Sakon M, Monden M. Nagano H, et al. Among authors: monden m. Nihon Rinsho. 2002 Nov;60(11):2237-44. Nihon Rinsho. 2002. PMID: 12440136 Review. Japanese.

4

[The chemotherapy for hepatocellular carcinoma].

Nagano H, Sakon M, Monden M. Nagano H, et al. Among authors: monden m. Gan To Kagaku Ryoho. 2003 Nov;30(12):1895-900. Gan To Kagaku Ryoho. 2003. PMID: 14650956 Review. Japanese.

5

Interferon-beta is more potent than interferon-alpha in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs.

Damdinsuren B, Nagano H, Sakon M, Kondo M, Yamamoto T, Umeshita K, Dono K, Nakamori S, Monden M. Damdinsuren B, et al. Among authors: monden m. Ann Surg Oncol. 2003 Dec;10(10):1184-90. doi: 10.1245/aso.2003.03.010. Ann Surg Oncol. 2003. PMID: 14654475

6

Interstitial pneumonia induced by combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma.

Yamamoto S, Tomita Y, Hoshida Y, Iizuka N, Marubashi S, Miyamoto A, Nagano H, Dono K, Umeshita K, Nakamori S, Sakon M, Aozasa K, Monden M. Yamamoto S, et al. Among authors: monden m. J Gastroenterol. 2004 Aug;39(8):793-7. doi: 10.1007/s00535-004-1375-0. J Gastroenterol. 2004. PMID: 15338375

7

Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma.

Kurokawa Y, Matoba R, Nagano H, Sakon M, Takemasa I, Nakamori S, Dono K, Umeshita K, Ueno N, Ishii S, Kato K, Monden M. Kurokawa Y, et al. Among authors: monden m. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6029-38. doi: 10.1158/1078-0432.CCR-04-0243. Clin Cancer Res. 2004. PMID: 15447987

8

[Influence on 5-fluorouracil metabolism by combination of interferon-alpha and 5-fluorouracil against human hepatocellular carcinoma xenografts].

Jin CD, Yamamoto T, Nakamura M, Arai I, Kishin R, Xing X, Nagano H, Dono K, Umeshita K, Nakamori S, Sakon M, Monden M. Jin CD, et al. Among authors: monden m. Gan To Kagaku Ryoho. 2004 Oct;31(10):1511-5. Gan To Kagaku Ryoho. 2004. PMID: 15508442 Japanese.

9

Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.

Yamamoto T, Nagano H, Sakon M, Wada H, Eguchi H, Kondo M, Damdinsuren B, Ota H, Nakamura M, Wada H, Marubashi S, Miyamoto A, Dono K, Umeshita K, Nakamori S, Yagita H, Monden M. Yamamoto T, et al. Among authors: monden m. Clin Cancer Res. 2004 Dec 1;10(23):7884-95. doi: 10.1158/1078-0432.CCR-04-0794. Clin Cancer Res. 2004. PMID: 15585621

10

Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.

Kondo M, Nagano H, Wada H, Damdinsuren B, Yamamoto H, Hiraoka N, Eguchi H, Miyamoto A, Yamamoto T, Ota H, Nakamura M, Marubashi S, Dono K, Umeshita K, Nakamori S, Sakon M, Monden M. Kondo M, et al. Among authors: monden m. Clin Cancer Res. 2005 Feb 1;11(3):1277-86. Clin Cancer Res. 2005. PMID: 15709199

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

904 results

Search Page

Filters